Skip to main content

MoneyWorks4Me

Makers Laboratories - Quaterly Results

05 Nov 2026 Evaluate
The Revenue for the quarter ended  September 2026 of Rs. 139.22 millions grew by 10.13 % from Rs. 126.41 millions.The Total Profit for the quarter ended September 2026 of Rs. 6.57 millions grew from Rs.-3.12 millionsOperating Profit saw a handsome growth to 17.27 millions from 4.51 millions in the quarter ended September 2026.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 139.22 126.41 10.13 241.10 263.68 -8.56 503.47 429.45 17.24
Other Income 5.29 5.27 0.38 6.01 5.66 6.18 5.93 109.24 -94.57
PBIDT 17.27 4.51 282.93 12.99 9.53 36.31 13.23 87.15 -84.82
Interest 1.41 1.54 -8.44 2.77 2.56 8.20 5.31 9.40 -43.51
PBDT 15.86 2.97 434.01 10.22 6.97 46.63 7.92 77.75 -89.81
Depreciation 7.01 7.06 -0.71 13.95 14.05 -0.71 28.04 28.46 -1.48
PBT 8.85 -4.09 -316.38 -3.73 -7.08 -47.32 -20.12 49.29 -140.82
TAX 2.28 -0.97 -335.05 0.46 -1.25 -136.80 -2.92 2.87 -201.74
Deferred Tax 2.28 -0.97 -335.05 0.46 -1.25 -136.80 -2.92 2.88 -201.39
PAT 6.57 -3.12 -310.58 -4.19 -5.83 -28.13 -17.20 46.42 -137.05
Equity 59.00 59.00 0.00 59.00 59.00 0.00 59.00 59.00 0.00
PBIDTM(%) 12.40 3.57 247.69 5.39 3.61 49.07 2.63 20.29 -87.05
Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..